Wednesday, February 29, 2012

Skin cancer drug, vemurafenib may prolong survival in advanced cases: Study

›
In continuation of my update on  vemurafenib ... According to an international study a new treatment for advanced  skin cancer  almo...
Tuesday, February 28, 2012

FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa

›
In continuation of my up date on Qnexa FDA panel votes in favor of earlier rejected anti-obesity drug Qnexa : Qnexa took a step closer to ap...
Sunday, February 26, 2012

Melanoma Drug Nearly Doubles Survival « VICC News & Publications

›
In continuation of my update on Zelboraf ( vemurafenib ) Melanoma Drug Nearly Doubles Survival « VICC News & Publications
Saturday, February 25, 2012

FDA Approves Korlym for Patients with Endogenous Cushing's Syndrome..

›
Korlym (mifepristone) was approved by the U.S. Food and Drug Administration to control high blood sugar levels (hyperglycemia) in a...
Friday, February 24, 2012

FDA Approves Zioptan (tafluprost ophthalmic solution), Merck's Once-Daily, Preservative-Free Ophthalmic Medication

›
U.S. Food and Drug Administration (FDA) has approved Zioptan   (tafluprost ophthalmic solution) 0.0015%, the first preservative-free p...

Compound makes imipenem 16 times more effective against antibiotic-resistant K. pneumoniae

›
North Carolina State University chemists have created a compound (see structure above - when used in conjunction with the antibiotic ...
Thursday, February 23, 2012

Prescription Shampoo (with Ivermectin) Approved to Treat Head Lice

›
In continuation of my update on  ivermectin                                      Sklice  Lotion, a prescription-strength shampoo to...
Tuesday, February 21, 2012

Case Western Reserve University - One of the nation's top universities and the best college in Ohio

›
Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure f...
Monday, February 20, 2012

Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol

›
The U.S. Food and Drug Administration (FDA) has approved Mitosol ( mitomycin for solution) for use in glaucoma surgery. "The appro...
Sunday, February 19, 2012

FDA Approves Kalydeco to Treat Rare Form of Cystic Fibrosis

›
The U.S. FDA approved  Kalydeco  (ivacaftor) for the treatment of a rare form of cystic fibrosis (CF) in patients ages 6 years and older who...
Saturday, February 18, 2012

Clazosentan reduces risk of blood vessel spasm in patients with brain aneurysm

›
Clazosentan reduces risk of blood vessel spasm in patients with brain aneurysm : An experimental drug, clazosentan, reduced the risk of bloo...
Friday, February 17, 2012

Genentech receives FDA approval for Vismodegib to treat skin cancer

›
In continuation of my update Vismdegib Genentech receives FDA approval for Vismodegib to treat skin cancer : A new skin cancer drug tested...
Thursday, February 16, 2012

Colchicine, another weapon against cancer

›
In continuation of my update on Colchine  Colchicine, another weapon against cancer : Finding a drug that targets only the diseased cells i...
Wednesday, February 15, 2012

Scientists discover new mechanisms by which RNA drugs can control gene activity

›
 In continuation of my update on RNAi Short strands of nucleic acids, called small RNAs, can be used for targeted gene silencing, making t...
Tuesday, February 14, 2012

Researchers identify fexinidazole as potential new therapy for visceral leishmaniasis

›
Researchers at the University of Dundee have identified fexinidazole as a possible, much-needed, new treatment for the parasitic disease vi...